About Us

InGeneron, Inc.
8275 El Rio Street
Suite 130
Houston, TX 77054
713-440-9900 p
713-440-6299 f
info@ingeneron.com

Board of Directors

Eckhard Alt, MD PhD has been Chairman of the Board of InGeneron, Inc since 2006. Dr. Alt is also Chairman of the Board of MediaCS, Inc located in Houston, TX and since 2001 he has been the Chairman of the Supervisory Board of the Isar Klinik II AG in Munich, Germany. Dr. Alt was the past Chairman of the Supervisory Board of InFlow Dynamics AG, and he has served as a consultant to EP Med Systems, Inc, Guidant, Inc, Intermedics, Inc, and Medtronic, Inc. He has held leadership positions in numerous medical societies including the Advisory Panel for the World Medical Association, and being a founding member of the European Heart Rhythm Association and the European Cardiac Arrhythmia Society. He is an active researcher and a prolific inventor, holding more than 600 patents worldwide. Dr. Alt currently holds the position of Professor in the Department of Molecular Pathology at the University of Texas MD Anderson Cancer Center. In addition, Dr Alt holds appointments as Professor of Medicine and Adjunct Professor of Biomedical Engineering at Tulane University Health Science Center and Professor of Medicine at Technische Universitaet in Munich Germany. Dr. Alt received his MD, graduating at the top of his class, from the University of Heidelberg in Germany.

Jerry C. Griffin, M.D. is president of Griffin & Schwartz, Scientific Services, Inc. a management consulting firm in the healthcare products field. Dr. Griffin has assisted several development stage companies in areas ranging from venture and public financing to FDA and clinical trial strategy. In addition, he is currently a member of the Boards of Directors of 2 public and 4 private companies. From 1999-2006 Dr. Griffin was President, CEO and a Director of POINT Biomedical Corp. where he led the company through the clinical development and submission of a New Drug Application (NDA) to the FDA for a novel pharmaceutical agent for ultrasound myocardial perfusion. Prior to joining POINT, Dr. Griffin, was Executive Vice President of InControl, Inc., a cardiovascular medical device company. Dr. Griffin was responsible for overseeing InControl’s clinical and regulatory programs and establishing a worldwide strategy for its devices for treating atrial fibrillation, a major cardiovascular disorder. InControl was acquired by the Guidant Corporation in September, 1998. Dr. Griffin was Professor of Medicine at the University of California at San Francisco and held a faculty position there from 1984 to 1995. He also served on the faculties of Stanford University Medical School and Baylor College of Medicine. During his academic tenure, he held leadership positions in several national and international cardiology organizations and is the author or co-author of 5 books, 4 patents, and over 170 medical and scientific articles. He holds a B.S. degree from the University of Southern Mississippi, an M.D. degree from the University of Mississippi School of Medicine, and received his Cardiology training at Stanford University Medical Center.

Edwin K. Hunter practices law in Texas, Louisiana and the District of Columbia. He graduated from the LSU Law Center where he was a member of Order of the Coif and an editor of the Louisiana Law Review. Edwin has served as chairman of the Louisiana State Bar Association’s Section on Taxation and the Board of Specialization. He is a director of Ascension Orthopedics, Inc, a co-manager of Mountain Brook Water Company, LLC and a trustee of the Joe W. and Dorothy Dorsett Brown Foundation, the Fritz Lang Foundation, the Olive Tupper Foundation and the Chambers Medical Foundation.